[1] Sebode M, Weiler-Normann C, Liwinski T, et al. Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance. Front Immunol,2018, 9:609-620.
[2] Yang F, Wang Q, Jia J, et al. Autoimmune Hepatitis: East Meets West. J Gastroenterol Hepatol, 2015, 30:1230-1236.
[3] De VR, La AC, Matarese G: Metabolic pressure and the breach of immunological self-tolerance. Nat Immunol, 2017, 18:1190-1196.
[4] Richards JL, Yap YA, Mcleod KH, et al. Dietary metabolites and the gut microbiota: an alternative approach to control inflammatory and autoimmune diseases. Clin Transl Immunology, 2016, 5:82-89.
[5] Czaja AJ: Emerging therapeutic biomarkers of autoimmune hepatitis and their impact on current and future management. Expert Rev Gastroenterol Hepatol 2018.28:21-39.
[6] Joshita S, Yoshizawa K, Umemura T, et al. Clinical features of autoimmune hepatitis with acute presentation: a Japanese nationwide survey. J Gastroenterol, 2018,5:1-10.
[7] Ganeshan K, Chawla A: Metabolic regulation of immune responses. Annu Rev Immunol, 2014, 32:609-634.
[8] Pearce, Erika, nbsp, et al. Metabolic Pathways in Immune Cell Activation and Quiescence. Immunity, 2013, 38:633-643.
[9] Robertson LT, Mitchell JR: Benefits of short-term dietary restriction in mammals. Exp Gerontol, 2013, 48:1043-1048.
[10] Fehervari Z: Caloric restriction and type 2 immunity. Nat Immunol,2016, 17:1243-1243. |
